
Abbott Laboratories ABT
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.74 B |
Market Cap[1] |
$ 197 B |
EBITDA (LTM) |
$ 8.99 B |
P/E (LTM) |
42.962825 |
P/S (LTM) |
4.171917 |
EPS (LTM) |
2.69 |
Abbott Laboratories is a global healthcare company founded in 1888. The company develops and manufactures a wide range of medical devices, diagnostics, and nutritional products. Abbott's products and services are used by healthcare professionals and patients in over 160 countries.
Abbott is known for its innovative solutions for healthcare challenges. The company invests heavily in research and development to develop new products and technologies that improve patient outcomes and reduce healthcare costs. Abbott's areas of focus include cardiovascular, diabetes care, diagnostic imaging, infectious diseases, nutrition, and pharmaceuticals.
Abbott is committed to social responsibility and sustainability. The company aims to reduce its environmental impact and promote the use of renewable energy. Abbott also supports community health initiatives and disaster relief efforts around the world.
Overall, it's a significant player in the healthcare industry, with a strong commitment to innovation, quality, and sustainability. The company's products and services have a significant impact on patient outcomes and the global healthcare system.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Electromed
ELMD
|
$ 26.83 | -5.53 % | $ 222 M | NYSE American | ||
|
Inogen
INGN
|
$ 6.78 | -6.09 % | $ 180 M | Nasdaq Global Select Market,SPB | ||
|
Globus Medical
GMED
|
$ 81.19 | -6.74 % | $ 11 B | NYSE,SPB | ||
|
IRadimed Corporation
IRMD
|
$ 85.34 | -3.66 % | $ 1.09 B | Nasdaq Global Select Market | ||
|
ClearPoint Neuro
CLPT
|
$ 8.7 | -14.37 % | $ 246 M | Nasdaq Capital Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.12 | -18.04 % | $ 14.7 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 48.48 | -5.59 % | $ 2.23 B | Nasdaq Capital Market,SPB | ||
|
IRIDEX Corporation
IRIX
|
$ 0.69 | -3.51 % | $ 11.7 M | Nasdaq Global Select Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 4.6 | 0.88 % | $ 286 M | Nasdaq Capital Market | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 14.14 | -4.62 % | $ 1.08 B | Nasdaq Global Select Market,SPB | ||
|
Bruker Corporation
BRKR
|
$ 58.05 | -9.01 % | $ 8.81 B | Nasdaq Global Select Market,SPB | ||
|
LivaNova PLC
LIVN
|
$ 91.2 | -3.17 % | $ 4.97 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 5.46 | -6.51 % | $ 65.3 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 2.57 | -9.36 % | $ 105 M | Nasdaq Global Select Market | ||
|
Penumbra
PEN
|
$ 320.73 | -0.55 % | $ 12.5 B | NYSE,SPB | ||
|
InspireMD
NSPR
|
$ 0.64 | -18.18 % | $ 41.2 M | NYSE American | ||
|
InMode Ltd.
INMD
|
$ 13.42 | -5.53 % | $ 867 M | Nasdaq Global Select Market,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 32.1 | -4.21 % | $ 753 M | Nasdaq Global Select Market,SPB | ||
|
Outset Medical
OM
|
$ 4.06 | -8.56 % | $ 61.8 M | Nasdaq Global Select Market | ||
|
PAVmed
PAVM
|
$ 1.55 | -6.63 % | $ 1.04 M | Nasdaq Capital Market | ||
|
AVITA Medical
RCEL
|
$ 15.71 | -3.74 % | $ 438 M | Nasdaq Global Select Market | ||
|
Tactile Systems Technology
TCMD
|
$ 26.38 | -3.31 % | $ 603 M | Nasdaq Global Select Market,SPB | ||
|
Xtant Medical Holdings
XTNT
|
$ 0.3 | 1.66 % | $ 41.9 M | NYSE American | ||
|
Viemed Healthcare
VMD
|
$ 9.01 | -10.88 % | $ 350 M | Nasdaq Global Select Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 7.38 | 0.96 % | $ 997 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 66.45 | -0.13 % | $ 1.95 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 126.73 | 0.07 % | $ 4.4 B | NYSE,SPB | ||
|
Avanos Medical
AVNS
|
$ 24.99 | - | $ 1.16 B | NYSE,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Helius Medical Technologies
HSDT
|
$ 1.92 | -8.57 % | $ 42.3 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
- | - | $ 140 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Ra Medical Systems
RMED
|
- | 10.0 % | $ 610 K | NYSE American | ||
|
ReWalk Robotics Ltd.
RWLK
|
- | 7.07 % | $ 66.1 M | Nasdaq Global Select Market | ||
|
STRATA Skin Sciences
SSKN
|
- | - | $ 6.6 M | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
Align Technology
ALGN
|
$ 159.59 | -3.22 % | $ 11.6 B | Nasdaq Global Select Market,SPB | ||
|
Edwards Lifesciences Corporation
EW
|
$ 100.8 | 1.39 % | $ 58.9 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.